A model for interactions between immune cells and HIV considering drug treatments
- 110 Downloads
In this work, we analyze the capacity of the human body to combat HIV. The model here treated takes into consideration four types of defense of an organism infected by HIV: susceptible defense cells, the infected immune cells, killer T cells, and the HIV-specific killer T cells. This model, therefore, analyzes the interactions between the responses of killer T cells and HIV infections, evidencing how the immune system is attacked and how it defends. An optimal control problem is proposed to derive an optimal sequence of dosages in the standard drug treatment, in such a way as to minimize the side effects.
KeywordsHIV Mathematical modelling Optimal control
Mathematics Subject Classification97M10 49J15 97M40
This work was partially supported by the Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro, FAPERJ, under Grant no. E-26/202.789/2015, and by the Brazilian National Research Council-CNPq, under Grants 303543/2015-9.
- Adams BM, Banks HT, dae Kwon H, Tran HT (2004) Dynamic multidrug therapies for HIV: optimal and STI control approaches. Math Biosci Eng 1:223–241Google Scholar
- De Boer RJ (2002) Mathematical models of human CD4 T-cell population kinetics. Neth J Med 60:17–26Google Scholar
- Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, Siliciano RF (1999) Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5:512–7CrossRefGoogle Scholar
- Heesterbeek H, Anderson R, Andreasen V, Bansal S, De Angelis D, Dye C, Eames KTD, Edmunds WJ, Frost SDW, Funk S, Hollingsworth TD, House T, Isham V, Klepac P, Lessler J, Lloyd-Smith JO, Metcalf CJE, Mollison D, Pellis L, Pulliam JRC, Roberts MG, Viboud C (2015) Modeling infectious disease dynamics in the complex landscape of global health. Science 347. https://doi.org/10.1126/science.aaa4339
- Kamata M, Kim PY, Ng HL, Ringpis GE, Kranz E, Chan J, O’Connor S, Yang OO, Chen IS (2015) Ectopic expression of anti-HIV-1 shRNAs protects CD8+ T cells modified with CD4\(\zeta \) CAR from HIV-1 infection and alleviates impairment of cell proliferation. Biochem Biophys Res Commun 463:216–221. https://doi.org/10.1016/j.bbrc.2015.05.026 CrossRefGoogle Scholar
- Kilby JM, Goepfert PA, Miller AP, Gnann Jr. JW, Sillers M, Saag MS, Bucy RP (2000) Recurrence of the acute hiv syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: a case report. Ann Intern Med 133:435–438. https://doi.org/10.7326/0003-4819-133-6-200009190-00011, http://arXiv:/data/journals/aim/19965/0000605-200009190-00011.pdf
- Kirk DE (1970) Optimal control theory: an introduction. Prentice-Hall, Englewood CliffsGoogle Scholar
- Lewis F, Syrmos V (1995) Optimal control. Wiley, New YorkGoogle Scholar
- Pinkevych M, Cromer D, Tolstrup M, Grimm AJ, Cooper DA, Lewin SR, Søgaard OS, Rasmussen Thomas, A, Kent SJ, Kelleher AD, Davenport MP (2015) HIV reactivation from latency after treatment interruption occurs on average every 5–8 days—implications for HIV remission. PLoS Pathog 11:1–19. https://doi.org/10.1371/journal.ppat.1005000 CrossRefGoogle Scholar
- Pontryagin LS, Boltyanskij VG, GamKrelidze RV, Mishchenko EF (1961) The mathematical theory of optimal processes. Interscience Publishers, New YorkGoogle Scholar